New York State Teachers Retirement System (NYSTRS)’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-27,200
Closed -$298K 1637
2023
Q3
$298K Hold
27,200
﹤0.01% 1476
2023
Q2
$360K Sell
27,200
-2,217
-8% -$31.6K ﹤0.01% 1463
2023
Q1
$400K Buy
29,417
+300
+1% +$5.38K ﹤0.01% 1449
2022
Q4
$569K Sell
29,117
-100
-0.3% -$1.95K ﹤0.01% 1380
2022
Q3
$557K Buy
29,217
+7,900
+37% +$182K ﹤0.01% 1368
2022
Q2
$439K Buy
21,317
+15,217
+249% +$361K ﹤0.01% 1423
2022
Q1
$196K Buy
+6,100
New +$222K ﹤0.01% 1530

Other funds holding ITOS

New York State Teachers Retirement System (NYSTRS)'s ITOS Position: Q4 2023 in Review

New York State Teachers Retirement System (NYSTRS) sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 27,200 shares — an estimated $298K sold.

New York State Teachers Retirement System (NYSTRS) first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $569K in Q4 2022. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • New York State Teachers Retirement System (NYSTRS) reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • New York State Teachers Retirement System (NYSTRS) sold 27,200 iTeos Therapeutics shares in Q4 2023, an estimated $298K.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
  • New York State Teachers Retirement System (NYSTRS)'s iTeos Therapeutics position peaked at $569K in Q4 2022.
  • 138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q4 2023, filed 24 Jan 2024.